Literature DB >> 10897626

[Changing clinical course of hemolytic uremic syndrome in children].

A Zurowska1, Z Gockowska, P Czarniak, E Marczak.   

Abstract

An incidence of hemolytic-uraemic syndrome as a cause of the acute renal failure in childhood, its early survival rate and long-term sequela quences were compared in the 1970s, 1980s, and 1990s in the same geographical area. 196 children with HUS were treated between 1972-1999. 94% had a typical D+ HUS. The majority were of patients severely ill with 87% requiring peritoneal dialysis of an average 14 days duration. The children were grouped into three 9-year periods for comparison (1972-1980, 1981-1989, 1990-1999). 105 patients were followed for 2-27 years (mean 1 years). An incidence of HUS as a cause of ARF in childhood ranged from 58% and 50% in the 1970s and 1980s to 30% in the past decade. With time survival rate has improved dramatically over the years from 80% and 75% to 97% in the 1990s. Deo spite better short term outcome the late consequences of HUS are serious. The longer the follow-up, the greater percentage of patients with severe outcome. At last follow-up only 32% children showed full recovery. 33% are on renal replacement therapy or have impaired renal function. The severity of the initial lesions to the kidney measured by the duration of anuria is a marker of poor late prognosis. With improving early outcome the clinical significance of HUS is focusing on its severe long-term consequences.

Entities:  

Mesh:

Year:  2000        PMID: 10897626

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome.

Authors:  Randall Lou-Meda; Robert S Oakes; Jarom N Gilstrap; Christopher G Williams; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2006-09-12       Impact factor: 3.714

2.  Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Authors:  Robert S Oakes; Justin K Kirkham; Justin K Kirkhamm; Raoul D Nelson; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2008-05-09       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.